Market Overview:
The global epigenetics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 16% during 2021-2026.
Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.
Epigenetics Market Trends:
The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global epigenetics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, technology and application.
Breakup by Product:
- Reagents
- Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
- Instruments
- Enzymes
- Services
Breakup by Technology:
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large Non-Coding RNA
- MicroRNA Modification
- Chromatin Structures
Breakup by Application:
- Oncology
- Solid Tumors
- Liquid Tumors
- Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.
Report Coverages:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Technology, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global epigenetics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global epigenetics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global epigenetics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Epigenetics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Kits
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Chip Sequencing Kit
6.2.2.2 Whole Genomic Amplification Kit
6.2.2.3 Bisulfite Conversion Kit
6.2.2.4 RNA Sequencing Kit
6.2.2.5 Others
6.2.3 Market Forecast
6.3 Instruments
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Enzymes
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Services
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Technology
7.1 DNA Methylation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Histone Methylation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Histone Acetylation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Large Non-Coding RNA
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 MicroRNA Modification
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Chromatin Structures
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Oncology
8.1.1 Market Trends
8.1.2 Key Segments
8.1.2.1 Solid Tumors
8.1.2.2 Liquid Tumors
8.1.3 Market Forecast
8.2 Non-Oncology
8.2.1 Market Trends
8.2.2 Key Segments
8.2.2.1 Inflammatory Diseases
8.2.2.2 Metabolic Diseases
8.2.2.3 Infectious Diseases
8.2.2.4 Cardiovascular Diseases
8.2.2.5 Others
8.2.3 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abcam plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Active Motif Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Agilent Technologies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Diagenode Diagnostics (Hologic Inc)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Illumina Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 PerkinElmer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Roche Holding AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Thermo Fisher Scientific Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Zymo Research Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
List of Figures
Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
Figure 2: Global: Epigenetics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2020
Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2020
Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2020
Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2020
Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: North America: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: United States: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Canada: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: China: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Japan: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: India: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: South Korea: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Australia: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Others: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Europe: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Germany: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: France: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Italy: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Spain: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Russia: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Latin America: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Brazil: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Mexico: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Others: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2020
Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Global: Epigenetics Industry: SWOT Analysis
Figure 84: Global: Epigenetics Industry: Value Chain Analysis
Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Epigenetics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Epigenetics Market: Competitive Structure
Table 7: Global: Epigenetics Market: Key Players